A detailed history of Presilium Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Presilium Private Wealth, LLC holds 478 shares of LLY stock, worth $488,372. This represents 0.07% of its overall portfolio holdings.

Number of Shares
478
Previous 435 9.89%
Holding current value
$488,372
Previous $339 Million 7.55%
% of portfolio
0.07%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$625.65 - $812.69 $26,902 - $34,945
43 Added 9.89%
478 $365 Million
Q2 2025

Jul 25, 2025

BUY
$713.71 - $898.95 $310,463 - $391,043
435 New
435 $339 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Presilium Private Wealth, LLC Portfolio

Follow Presilium Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Presilium Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Presilium Private Wealth, LLC with notifications on news.